Bristol-Myers Squibb (BMY) PT Raised to $80 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Bristol-Myers Squibb Reports First Quarter Financial Results
April 28, 2016 6:59 AM EDTIncreases First Quarter Revenues 9% to $4.4 Billion Posts First Quarter GAAP EPS of $0.71 and Non-GAAP EPS of $0.74 Achieves Significant European Regulatory Milestones in Immuno-Oncology Opdivo Approved for Previously Treated Advanced Renal Cell Carcinoma Expanded Use of Opdivo to Include Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer Positive Advisory Opinions for Opdivo + Yervoy Regimen and Empliciti Validation of Application for Opdivo in Classical Hodgkin Lymphoma... More
